fda tirzepatide update today approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA Announces End To Compounded

The amount of weight lost varies between individuals, but studies have shown significant weight loss in participants using Ozempic combined with lifestyle interventions like diet and exercise

Questions to ask your provider Before your first injection, get clear answers to these questions

They can schedule unlimited check-ins with their healthcare team to address side effects, adjust dosages, or ask questions all at no extra cost

Ozempic is FDA-approved for type 2 diabetes, and weight loss can happen as a side effect

Maintaining open communication with your healthcare providers ensures safe, effective use of all your medications whilst supporting your overall health and weight management objectives

Structurally, it is an analogue of the native GIP sequence, modified to include a C20 fatty di-acid moiety